Literature DB >> 16139567

Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?

Peter Heeringa1, Dennis Huugen, Jan Willem Cohen Tervaert.   

Abstract

Anti-neutrophil cytoplasmic autoantibodies (ANCA) with specificity for myeloperoxidase (MPO) or proteinase 3 (Pr3) are associated with systemic small-vessel vasculitides (SVV). Detection of ANCA is an established clinical tool in disease diagnosis and monitoring. Based on clinical and in vitro experimental evidence, a pathogenic role for ANCA has long been suspected, however, in vivo models in which causality can be tested have been lacking. Recently, an exciting novel rat model of MPO-ANCA-associated vasculitis has been described, which provides compelling evidence that MPO-ANCA are a primary pathogenic factor in SVV by augmenting leukocyte-endothelial interactions and vascular wall damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139567     DOI: 10.1016/j.it.2005.08.010

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  9 in total

Review 1.  Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?

Authors:  Jan Willem Cohen Tervaert; Jan Damoiseaux
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

2.  Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo.

Authors:  Sarah L Nolan; Neena Kalia; Gerard B Nash; Dia Kamel; Peter Heeringa; Caroline O S Savage
Journal:  J Am Soc Nephrol       Date:  2008-02-27       Impact factor: 10.121

3.  IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.

Authors:  Mirjan M van Timmeren; Betty S van der Veen; Coen A Stegeman; Arjen H Petersen; Thomas Hellmark; Mattias Collin; Peter Heeringa
Journal:  J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 10.121

Review 4.  Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides.

Authors:  Ora Shovman; Boris Gilburd; Gisele Zandman-Goddard; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

5.  Health-related quality of life for patients with vasculitis and their spouses.

Authors:  Delesha M Carpenter; Carolyn T Thorpe; Megan Lewis; Robert F Devellis; Susan L Hogan
Journal:  Arthritis Rheum       Date:  2009-02-15

6.  Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes.

Authors:  Ymke M van der Geld; Thomas Hellmark; Daina Selga; Peter Heeringa; Minke G Huitema; Pieter C Limburg; Cees G M Kallenberg
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

Review 7.  Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis.

Authors:  J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2009-03-20       Impact factor: 4.330

8.  Sudden and rapid progression of lung affectation but stability in kidney function: a case report of anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Cheng Chen; Ye-Han Zhu; Hong-Ying Qian; Ling-Yi Yang; Jian-An Huang
Journal:  Int Med Case Rep J       Date:  2013-12-31

9.  Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity.

Authors:  Olivier M Lardinois; Leesa J Deterding; Jacob J Hess; Caroline J Poulton; Candace D Henderson; J Charles Jennette; Patrick H Nachman; Ronald J Falk
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.